In this study, TriL dose-dependently ameliorated I/R-induced cerebral injury, including reduced infarct size and functional deficits, and mitigated neuronal apoptosis, revealing the neuroprotective effect of TriL on cerebral ischemia partially via the anti-oxidative and anti-inflammatory effects. Here, TRIL is linked to Cerebral ischemia.